AstraZeneca has claimed FDA approval for its first-in-class pan-AKT inhibitor capivasertib, getting a green light for the drug as a treatment for breast cancer, but with a more restrictive label than ...
For over 30 years, Life Line Screening has provided preventive health screenings for stroke and cardiovascular disease risk in community-based buildings. Its screenings are noninvasive, painless and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results